News Releases
All Releases
View Summary Peregrine Pharmaceuticals Presents Advances in Vascular and Tumor Targeting Technologies at American Association for Cancer Research Annual Meeting
Apr 9, 2002
PDF 10.6 KB Add to Briefcase
View Summary Avid Bioservices Announces Manufacturing Supply Agreement With Inhibitex for the Production of Therapeutic Monoclonal Antibodies
Mar 19, 2002
PDF 6.9 KB Add to Briefcase
View Summary Peregrine Announces Quarterly Conference Call
Mar 18, 2002
PDF 6.8 KB Add to Briefcase
View Summary Avid Bioservices Announces Manufacturing Supply Agreement for the Production of a Therapeutic Monoclonal Antibody Intended for Phase III Clinical Trials
Mar 13, 2002
PDF 7.2 KB Add to Briefcase
View Summary Avid Bioservices Enters Into a Manufacturing and Supply Agreement With Seradyn
Mar 6, 2002
PDF 6.6 KB Add to Briefcase
View Summary Peregrine Announces Grant of Patent for New Class of Vascular Targeting Agents
Mar 4, 2002
PDF 8.2 KB Add to Briefcase
View Summary Peregrine and OXiGENE Conclude Arcus Therapeutics LLC Joint Venture; Companies Reacquire Full Rights to Respective Vascular Targeting Technologies
Feb 28, 2002
PDF 9.8 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces $2.2 Million Investment From Institutional Investors
Feb 4, 2002
PDF 7.3 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces Grant of Patent for New Anti-Cancer Antibodies
Jan 29, 2002
PDF 9.2 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces Formation of Contract Manufacturing Subsidiary Avid Bioservices Inc.
Jan 8, 2002
PDF 10.0 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces the Initiation of Human Antibody Generation Against Two Additional Antigen Targets With Xenerex Biosciences
Dec 20, 2001
PDF 9.4 KB Add to Briefcase
View Summary Peregrine Announces Quarterly Conference Call
Dec 17, 2001
PDF 6.9 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces Publication of Data Demonstrating Similar Characteristics of Chimeric and Human TNT Monoclonal Antibodies
Dec 17, 2001
PDF 9.1 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces It has Agreed Upon the Design of a Phase III Study for Brain Cancer With the FDA; Study Will Treat Patients With Recurrent Glioblastoma Multiforme
Dec 13, 2001
PDF 9.3 KB Add to Briefcase
View Summary Peregrine Pharmaceuticals Announces $5.75 Million Investment From Institutional Investors; Company Director Invests in Offering
Nov 19, 2001
PDF 8.6 KB Add to Briefcase
View Summary Peregrine Announces Image Fusion Data From Phase II Cotara Trial; Data To Be Presented at the Meeting of the World Federation of Neuro-Oncology
Nov 16, 2001
PDF 9.1 KB Add to Briefcase
Showing 621-636 of 636 Page: 1 ... 28 29 30 31 32  Previous 20
Add to Briefcase = add release to Briefcase
Print E-mail